What Are Analysts Opinions On Seattle Genetics, Inc. (SGEN)
13 October, 2017, 04:44 | Author: Regina Silva
Since May 5, 2017, it had 0 insider purchases, and 3 selling transactions for $2.20 million activity.
ICON public limited company is a contract research organization, which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. However, dependence on one product - Adcetris- for growth has its inherent risks.The recent label expansion of Merck's Keytruda in the lymphoma indication is likely to increase competition.
Multiple company employees have indulged in significant insider trading. The company had Year Ago Sales of 106.31 Million. Estimates have remained stable ahead of the Q3 earnings results. On Friday, July 14 the stock rating was maintained by Barclays Capital with "Hold". Currently, the 14-day ADX for Seattle Genetics Inc (SGEN) is 43.89. The CCI technical indicator can be used to help determine if a stock is overbought or oversold.
There has been some selling insider activity on Seattle Genetics, Inc.
Some buy side analysts are also providing their Analysis on Seattle Genetics, Inc., where 2 analysts have rated the stock as Strong buy, 4 analysts have given a Buy signal, 9 said it's a HOLD, 1 reported it as Underperform and 0 analysts rated the stock as Sell.
Dias: GM's plans to produce Equinox in Mexico 'war on Canada'
But he said Dias could be making the situation worse by being so firm on demands for long-term commitments from the automaker. GM has ample unused factory space in the US , but retooling one of those plants to make the Equinox could take a few years.
Shares of Seattle Genetics Inc (SGEN) have a 200-day moving average of 58.89. The 14 day Williams %R for Seattle Genetics Inc (SGEN) is noted at -16.23. Icon plc had 23 analyst reports since July 29, 2015 according to SRatingsIntel. Moving averages are considered to be lagging indicators that simply take the average price of a stock over a certain period of time. Cognios Capital Llc who had been investing in Altria Group Inc for a number of months, seems to be less bullish one the $124.73 billion market cap company.
The average Wall Street analyst rating for Seattle Genetics, Inc.is Hold, according to the average of 13 analyst scores. The biotechnology company reported ($0.39) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.42) by $0.03. The business had revenue of $108.20 million during the quarter, compared to analysts' expectations of $105.92 million. The return on equity ratio or ROE stands at 2.6 percent while most common profitability ratio return on investment (ROI) was 5.1 percent. During the same period in the previous year, the company posted ($0.23) earnings per share. Next quarter's EPS is forecasted to be $-0.45 and the next full year EPS is anticipated to be $-1.22. Seattle Genetics Inc (SGEN) presently has a 14-day Commodity Channel Index (CCI) of 125.75. If you are reading this article on another domain, it was illegally stolen and reposted in violation of US & worldwide trademark and copyright legislation. The original version of this piece can be accessed at https://weekherald.com/2017/10/12/seattle-genetics-inc-sgen-stock-rating-upgraded-by-zacks-investment-research.html. The SEC filing shows that Himes Vaughn B performed a sale of 10,000 shares. The shares were sold at an average price of $54.54, for a total transaction of $545,400.00.
According to Seattle Genetics, Inc.'s latest 13F filing with the US Securities and Exchange Commission (SEC), institutional ownership is at 98.83%. Also, EVP Darren S. Cline sold 1,788 shares of the stock in a transaction dated Monday, August 28th. The stock was sold at an average price of $48.91, for a total transaction of $509,299.83. The disclosure for this sale can be found here. Vaughn B. Himes, CTO sold $530,900 worth of shares at an average price of $53.09 on Friday the 8th. (NASDAQ:SGEN). 20,200 are owned by Tributary Mgmt Ltd Liability Company.
Several large investors have recently made changes to their positions in SGEN. The stock witnessed 15.65% gains, 13.64% gains and -4.4% declines for the 1-month, 3-month and 6-month period, respectively. More interesting news about Seattle Genetics, Inc. Capital International Investors grew its position in Seattle Genetics by 34.3% during the second quarter. Goldman Sachs initiated the shares of SGEN in report on Wednesday, November 18 with "Sell" rating. Beta value of the stock is marked at 2.38. BlackRock Inc. grew its position in Seattle Genetics by 2.6% during the second quarter. More interesting news about Seattle Genetics, Inc. The Virginia-based Akre Capital Management Llc has invested 11.27% in the stock. Institutional investors own 97.63% of the company's stock.
Seattle Genetics, Inc is a biotechnology company focused on the development and commercialization of therapies for the treatment of cancer.
On average, equities research analysts forecast that Star Gas Partners, L.P. will post $0.55 EPS for the current fiscal year. National Bank & Trust Of Montreal Can invested in 0% or 3,725 shares. 2,000 were reported by Evercore Wealth Management.
In groups of four: "Under the orders of the budding rebellion, your team will travel to the molten planet of Mustafar ". Secrets of the Empire transports a team of players into the Star Wars world and can be experienced via The Void .
Abbott Laboratories (NYSE:ABT) touched its 1-Year High price of $55.43 on 10/10/17 and its 1-Year Low price of $37.38 on 12/01/16. The company has mean EPS estimate of 0.56 reported by 9 number of analyst for the quarter ending Current Qtr.(Sep2017).
Trelleborg is the southernmost town in Sweden , about 33km from Malmo, and has a history of gang violence. Aron Tydén told local newspaper Expressen: 'I was at home at my computer when I heard a loud bang.
Royal LePage is a Brookfield Real Estate Services Inc. company, a TSX-listed corporation trading under the symbol TSX:BRE. Ottawa maintained its stable momentum last quarter as prices increased by 7.9 per cent year-over-year to $441,453.
YorkBridge Wealth Partners LLC grew its holdings in shares of Anadarko Petroleum Corporation by 12.5% in the 2nd quarter. Cambrian Capital Limited Partnership decreased Anadarko Pete Corp (APC) stake by 38.22% reported in 2017Q2 SEC filing.
The entertainment giant reported $1.50 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.45 by $0.05. Bernstein reaffirmed a "market perform" rating on shares of Walt Disney Company (The) in a report on Tuesday, September 12th.
Stelac Advisory Services LLC purchased a new position in Wells Fargo & during the 2nd quarter valued at about $104,000. It has outperformed by 26.23% the S&P500.The move comes after 6 months positive chart setup for the $460.22M company.
The iPhone X also features Animoji, which are customized animated emoji that users can use to express their emotions on iMessage. Once Apple gets a handle on production, analysts are anticipating that demand for the iPhone X will be off the charts.
HSBC in July announced its third share buyback in a year as well as rising profits, in a sign of its turnaround. Flint spent his first 14 years with HSBC in Asia, establishing an investment bank in the region.
Shahid Kapoor shares cryptic message about "Padmavati"
People felt that he is being insecure due to Ranveer Singh who stole major limelight in the trailer and got trolled mercilessly. Well, the trailer and actors have been getting much love from their fans as well as B-town celebs.
Arsene Wenger hits back at Paul Merson jibe
And Arsenal fans weren't buying it as social media lit up with furious fans condemning their former star's freakish statement. Former England midfielder and current Sky Sports panellist Paul Merson is back with another baffling statement.
Oxford unveils plans for zero emission zone
A proposal headed to the Oxford City Council has four stages that would culminate in a city free of vehicular emissions by 2035. Oxford could be the first " zero emission zone" in the UK.